EDITORIALS


Acesso aberto Revisado por pares

0

Visualização

Promoting safer clozapine dosing in the Americas

Jose de Leon1,2, Trino Baptista3, Mariano Motuca4, Can-Jun Ruan5,6, Georgios Schoretsanitis7,8, Carlos De las Cuevas9

DOI: 10.47626/1516-4446-2021-0041

Epub: 24 de Junho de 2022

Vol.44 Issue 4/2022:

1Mental Health Research Center, Eastern State Hospital, Lexington, KY, USA
2Centro de Investigación Biomédica en Red de Salud Mental, Santiago Apóstol Hospital, University of the Basque Country, Vitoria, Spain
3Departamento de Fisiología, Facultad de Medicina, Universidad de los Andes, Mérida, Venezuela
4Instituto Vilapriño, Centro de Estudios, Asistencia e Investigación en Neurociencias, Mendoza, Argentina
5Laboratory of Clinical Psychopharmacology, Beijing Anding Hospital, Capital Medical University, Beijing, China
6The National Clinical Research Centre for Mental Disorders & Beijing Key Lab of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China
7Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zürich, Zürich, Switzerland
8The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, New York, USA
9Departamento de Medicina Interna, Dermatología y Psiquiatría, Instituto Universitario de Neurociencia, Universidad de La Laguna, Canary Islands, Spain

Corresponding author

Jose de Leon, Mental Health Research Center at Eastern State Hospital, 1350 Bull Lea Road, Lexington, KY 40511, USA. E-mail: jdeleon@uky.edu


© 2026 All rights reserved